<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02008604</url>
  </required_header>
  <id_info>
    <org_study_id>GUTSTROKE</org_study_id>
    <nct_id>NCT02008604</nct_id>
  </id_info>
  <brief_title>Influence of Stroke on the Composition of Intestinal Microbiota</brief_title>
  <acronym>GUTSTROKE</acronym>
  <official_title>Influence of Stroke on the Composition of Intestinal Microbiota (GUTSTROKE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prof. Dr. Ulrich Dirnagl, Experimental Neurology, Charité Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Christian Meisel, Medical Immunology, Charité Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PD Dr. Andreas Nitsche, Robert-Koch-Institut, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NeuroCure Clinical Research Center, Charite, Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to verify the hypothesis that the microbial colonisation of the gut
      is changed in patients after stroke and that the gut microbiome of severely affected stroke
      patients differs from that of patients with only a short disruption of blood circulation in
      the brain (transient ischemic attack, TIA). For this, the composition of gut microbiota in
      stool samples will be analyzed by 454 pyrosequencing. Further, the correlation of
      stroke-associated changes in the microbiome with immunological parameters will be analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>composition of intestinal microbiome</measure>
    <time_frame>change between day 1, day 4, day 7, day 14 after stroke</time_frame>
    <description>The composition of the intestinal metagenome / microbiome will be determined by analyzing the 16S rRNA by 454 Pyrosequencing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>test of correlation between most changed group of bacteria with changes in immunological parameters (HLA-DR)</measure>
    <time_frame>days 1, 4, 7 after stroke</time_frame>
    <description>Analysis of correlation between changes in microbiome (most changed group of bacteria, e.g. lactobacilli) with changes in immunological parameters (e.g. HLA-DR, IL-6, IL-10, CD4-lymphocytes from blood samples).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Stroke</condition>
  <condition>Transient Ischemic Attack (TIA)</condition>
  <arm_group>
    <arm_group_label>Stroke patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>TIA patients</arm_group_label>
    <description>patients with a transient ischemic attack (control group)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool samples, Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients at the rescue center, the Stroke Unit and the neurological intensive care unit of
        the Charité University hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18 and older

          -  ischemic cerebral infarction within the last 40 hours, anterior circulation infarct
             (ACA, MCA) and/or posterior circulation infarct (PCA, BA) of any severity

          -  patient consent or consent by a legal representative

          -  NIHSS &gt; or =9 (stroke patients)

          -  NIHSS &lt; 1 (for TIA patients)

        Exclusion Criteria:

          -  intracranial hemorrhage

          -  preexisting dysphagia

          -  signs of infection upon admission (clinical/paraclinical)

          -  existing antibiotic therapy upon admission or within the last 2 weeks before admission

          -  mechanical ventilation upon admission

          -  participation in an interventional therapy study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Meisel, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charite Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 15, 2013</study_first_submitted>
  <study_first_submitted_qc>December 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2013</study_first_posted>
  <last_update_submitted>November 28, 2018</last_update_submitted>
  <last_update_submitted_qc>November 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Andreas Meisel</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>ischemia</keyword>
  <keyword>stroke</keyword>
  <keyword>transient ischemic attack (TIA)</keyword>
  <keyword>microbiome</keyword>
  <keyword>microbiota</keyword>
  <keyword>gut</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

